The biosurgical agent market in Latin America will observe modest growth through 2032, primarily driven by surgical procedure volume growth, increasing evidence of the clinical benefits of…
The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in…
The biosurgical agent market in Europe will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
The Asia Pacific biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by the growing number of procedures in which in biosurgical agents are…
The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
The European biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, increasing procedure volume along with rising awareness of the clinical benefits of biosurgical…
The Asia Pacific biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, the overall market for biosurgical agent will exhibit modest growth over the forecast period…